Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manon van der Vlugt

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Crohn'S & Colitis|July 18, 2019
Risk of Progression of Low-Grade Dysplasia to Advanced Neoplasia in Inflammatory Bowel DiseaseMark Löwenberg, Manon Van Der Vlugt
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Future of Colorectal Cancer Screening: From One-Size-FITs-All to Tailor-MadeTim Kortlever, Manon van der Vlugt, Evelien Dekker
Gastroenterology|November 3, 2024
ReplyWillemijn de Klaver, Manon van der Vlugt, Evelien Dekker
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[How important is the quality of colonoscopy, considering the population screening for colorectal cancer?]Karlijn J Nass, Manon van der Vlugt, Evelien Dekker
Gastroenterology|January 22, 2018
ReplyManon van der Vlugt, Evelien Dekker, Patrick M Bossuyt
Gastroenterology|June 28, 2014
Acute dysphagia: don't wait and seeManon van der Vlugt, Judith Boone, Cyriel Y Ponsioen
Endoscopy|June 22, 2026
Reply to Qin et alQuerijn N E van Bokhorst, Evelien Dekker, Manon van der Vlugt
United European Gastroenterology Journal|May 19, 2018
A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomaticClasine M de Klerk, Manon van der Vlugt, Patrick M Bossuyt, et al.
Preventive Medicine Reports|June 25, 2021
Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screeningTim L Kortlever, Manon van der Vlugt, Evelien Dekker, et al.
Gastrointestinal Endoscopy|May 19, 2022
ResponseKarlijn J Nass, Manon van der Vlugt, Srivathsan Ravindran, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Crohn'S & Colitis|July 18, 2019
Risk of Progression of Low-Grade Dysplasia to Advanced Neoplasia in Inflammatory Bowel DiseaseMark Löwenberg, Manon Van Der Vlugt
Frontiers in Gastroenterology (Lausanne, Switzerland)|March 13, 2026
Future of Colorectal Cancer Screening: From One-Size-FITs-All to Tailor-MadeTim Kortlever, Manon van der Vlugt, Evelien Dekker
Gastroenterology|November 3, 2024
ReplyWillemijn de Klaver, Manon van der Vlugt, Evelien Dekker
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[How important is the quality of colonoscopy, considering the population screening for colorectal cancer?]Karlijn J Nass, Manon van der Vlugt, Evelien Dekker
Gastroenterology|January 22, 2018
ReplyManon van der Vlugt, Evelien Dekker, Patrick M Bossuyt
Gastroenterology|June 28, 2014
Acute dysphagia: don't wait and seeManon van der Vlugt, Judith Boone, Cyriel Y Ponsioen
Endoscopy|June 22, 2026
Reply to Qin et alQuerijn N E van Bokhorst, Evelien Dekker, Manon van der Vlugt
United European Gastroenterology Journal|May 19, 2018
A large proportion of fecal immunochemical test-positive participants in colorectal cancer screening is symptomaticClasine M de Klerk, Manon van der Vlugt, Patrick M Bossuyt, et al.
Preventive Medicine Reports|June 25, 2021
Individualized faecal immunochemical test cut-off based on age and sex in colorectal cancer screeningTim L Kortlever, Manon van der Vlugt, Evelien Dekker, et al.
Gastrointestinal Endoscopy|May 19, 2022
ResponseKarlijn J Nass, Manon van der Vlugt, Srivathsan Ravindran, et al.
Pageof 5